Cargando…

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients

Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in patients with cystic fibrosis infection and with a compromised immune system. Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molchanova, Natalia, Wang, Hengzhuang, Hansen, Paul R., Høiby, Niels, Nielsen, Hanne M., Franzyk, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391360/ https://www.ncbi.nlm.nih.gov/pubmed/30842761 http://dx.doi.org/10.3389/fmicb.2019.00275

Ejemplares similares

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
por: Molchanova, Natalia, et al.
Publicado: (2017)

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)

Adaptive Evolution of Escherichia coli to an α-Peptide/β-Peptoid Peptidomimetic Induces Stable Resistance
por: Hein-Kristensen, Line, et al.
Publicado: (2013)

Molecular Epidemiology of Chronic Pseudomonas aeruginosa Airway Infections in Cystic Fibrosis
por: Cramer, Nina, et al.
Publicado: (2012)

Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
por: Blanco-Aparicio, Marina, et al.
Publicado: (2019)

Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients
por: Bjarnsholt, Thomas, et al.
Publicado: (2010)

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)

Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection
por: Kolpen, Mette, et al.
Publicado: (2014)

Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions
por: Kolpen, Mette, et al.
Publicado: (2015)

Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate
por: Norman, Anders, et al.
Publicado: (2016)

Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host–pathogen interactions in cystic fibrosis
por: MOSER, CLAUS, et al.
Publicado: (2009)

Peptide/β-Peptoid Hybrids with Activity against Vancomycin-Resistant Enterococci: Influence of Hydrophobicity and Structural Features on Antibacterial and Hemolytic Properties
por: Vestergaard, Martin, et al.
Publicado: (2021)

Peptide/Peptoid Hybrid Oligomers: The Influence of Hydrophobicity and Relative Side-Chain Length on Antibacterial Activity and Cell Selectivity
por: Frederiksen, Nicki, et al.
Publicado: (2019)

Halogenation as a tool to tune antimicrobial activity of peptoids
por: Molchanova, Natalia, et al.
Publicado: (2020)

Effects of antibiotic treatment and phagocyte infiltration on development of Pseudomonas aeruginosa biofilm—Insights from the application of a novel PF hydrogel model in vitro and in vivo
por: Wu, Hong, et al.
Publicado: (2022)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Draft Genome Sequences of Pseudomonas aeruginosa B3 Strains Isolated from a Cystic Fibrosis Patient Undergoing Antibiotic Chemotherapy
por: Marvig, Rasmus Lykke, et al.
Publicado: (2013)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
por: Line, Laura, et al.
Publicado: (2014)

Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients
por: Candido Caçador, Natália, et al.
Publicado: (2018)

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation
por: Keating, Claire L., et al.
Publicado: (2021)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
por: Rada, Balázs
Publicado: (2017)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization
por: Andrea, Athina, et al.
Publicado: (2018)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients
por: van Mansfeld, Rosa, et al.
Publicado: (2016)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
por: Lingner, Meike, et al.
Publicado: (2017)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Zhao, Jingming, et al.
Publicado: (2018)

The antimicrobial lysine-peptoid hybrid LP5 inhibits DNA replication and induces the SOS response in Staphylococcus aureus
por: Gottschalk, Sanne, et al.
Publicado: (2013)

Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo
por: Zhang, Xiaodong, et al.
Publicado: (2021)

Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo
por: Wang, Yue, et al.
Publicado: (2022)

Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin In Vitro and In Vivo
por: Wang, Lingbo, et al.
Publicado: (2022)

Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways
por: Gabrielaite, Migle, et al.
Publicado: (2020)

Macrolide Resistance and In Vitro Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli
por: Ma, Yibing, et al.
Publicado: (2022)

Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection
por: Thomsen, Kim, et al.
Publicado: (2022)

151* Sino-pulmonary pairs of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients with chronic airways infection have similar gene expression profiles
por: Ciofu, O., et al.
Publicado: (2011)

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
por: Qvist, Tavs, et al.
Publicado: (2014)

Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by P. aeruginosa Isolated from Cystic Fibrosis Patients
por: Pani, Arianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_abccqc50ptomn943ea0dg0i4qe